PENETRATION OF FLEROXACIN INTO HUMAN AND ANIMAL-TISSUES

被引:10
作者
PORTMANN, R
WEIDEKAMM, E
机构
[1] Dept of Clinical Research, Hoffmann-La Roche Ltd
关键词
FLEROXACIN; TISSUE CONCENTRATION; TISSUE EXTRACTION;
D O I
10.1159/000238954
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fleroxacin concentrations in human and rat tissues were determined by HPLC following extraction with dichloromethane: isopropanol. This method yielded a high recovery of more than 85%. In the investigated tissues the fleroxacin levels were equal to or higher than those concomitantly measured in plasma. The concentration ratios 'tissue/plasma' were 1.6-2.7 for lung, 1.9-2.1 for muscle, 1.1-1.9 for gynaecological tissues and 1.2 for bone. Only in the case of fat and lens/eye lower ratios of 0.05-0.5 were found. The actual measured fleroxacin concentrations in most tissues and in plasma were high. Following oral administration of the recommended therapeutic dose of 400 mg, once daily, peak concentrations of 5-6 mg/l were reached in human plasma at steady state. Even 24 h after drug intake the fleroxacin level was still approximately 1 mg/l and thus in the range of the MIC90 values of susceptible bacteria causative for many types of tissue infections.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 12 条
[1]  
Andriole V., 1988, QUINOLONES
[2]   INVITRO ACTIVITY OF RO-23-6240, A NEW FLUORINATED 4-QUINOLONE [J].
CHIN, NX ;
BRITTAIN, DC ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :675-680
[3]   COMPARATIVE ORAL PHARMACOKINETICS OF FLEROXACIN AND PEFLOXACIN [J].
DELEPELEIRE, I ;
VANHECKEN, A ;
VERBESSELT, R ;
TJANDRAMAGA, TB ;
DESCHEPPER, PJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (02) :197-202
[4]  
DELL D, 1989, J LIQ CHROMATOGR, V11, P1299
[5]   STEADY-STATE PHARMACOKINETICS OF FLEROXACIN IN PATIENTS WITH SKIN AND SKIN STRUCTURE INFECTIONS [J].
HEIMDUTHOY, K ;
PELTIER, G ;
AWNI, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :922-923
[6]   FLEROXACIN - INVITRO ACTIVITY WORLDWIDE AGAINST 20,807 CLINICAL ISOLATES AND COMPARISON TO CIPROFLOXACIN AND NORFLOXACIN [J].
PAGANONI, R ;
HERZOG, C ;
BRAUNSTEINER, A ;
HOHL, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 :3-17
[7]   PHARMACOKINETICS AND TISSUE PENETRATION OF FLEROXACIN AFTER SINGLE AND MULTIPLE 400-MG-DOSAGE AND 800-MG-DOSAGE REGIMENS [J].
PANNETON, AC ;
BERGERON, MG ;
LEBEL, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (10) :1515-1520
[8]  
SORGEL F, 1988, J ANTIMICROB CHEMOTH, V22, P169
[9]   PHARMACOKINETICS AND BODY-FLUID PENETRATION OF FLEROXACIN IN HEALTHY-VOLUNTEERS [J].
SORGEL, F ;
METZ, R ;
NABER, K ;
SEELMANN, R ;
MUTH, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 :155-167
[10]   SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF FLEROXACIN, A TRIFLUORINATED QUINOLONE, IN HUMANS [J].
WEIDEKAMM, E ;
PORTMANN, R ;
SUTER, K ;
PARTOS, C ;
DELL, D ;
LUCKER, PW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1909-1914